Probiotic pre-administration reduces mortality in a mouse model of cecal ligation and puncture-induced sepsis
- PMID: 27588102
- PMCID: PMC4997999
- DOI: 10.3892/etm.2016.3534
Probiotic pre-administration reduces mortality in a mouse model of cecal ligation and puncture-induced sepsis
Abstract
A number of clinical trials have demonstrated that the use of probiotics has the potential to prevent nosocomial infections. However, the mechanism underlying probiotic-induced anti-infection and sepsis remains to be investigated. In the present study, 200 µl/day of Lactobacillus rhamnosus GG (LGG) or normal saline (control) was orally administrated to 4-week-old C57BL6 mice 4 weeks prior to cecal ligation and puncture (CLP). A number of mice were sacrificed 24 h after CLP, and the remaining mice were used for survival studies. Ileum tissues were collected to evaluate the injury on the intestine. Blood samples were also obtained to investigate the changed metabolic pattern in mice that underwent different treatments using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS). In the survival studies, the mortality of CLP-induced septic mice pretreated with LGG was significantly lower compared with untreated mice (P=0.029). Ileum mucosal damage was evident in the control septic mice. Based on the data of UPLC-QTOF-MS, phosphatidylcholines were increased and lysophosphatidylcholines (LPCs) that contained polyunsaturated fatty acids were decreased in septic mice, whereas saturated fatty acid LPCs reveal no significant difference between septic and sham mice. In addition, the metabolic profile in the septic mice pretreated with LGG was much closer to that of sham mice compared with control septic mice. The results of the present study suggest that probiotic pre-administration reduces the mortality in septic mice by decreasing ileum mucosal damage, increasing the gut barrier integrity and altering global serum metabolic profiles.
Keywords: Lactobacillus rhamnosus GG; cecal ligation and puncture; metabonomics; probiotic; sepsis; ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Figures




Similar articles
-
Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates microbiota dysbiosis in an experimental model of sepsis.Int J Mol Med. 2019 Mar;43(3):1139-1148. doi: 10.3892/ijmm.2019.4050. Epub 2019 Jan 7. Int J Mol Med. 2019. PMID: 30628657 Free PMC article.
-
Probiotic Lactobacillus rhamnosus GG reduces mortality of septic mice by modulating gut microbiota composition and metabolic profiles.Nutrition. 2020 Oct;78:110863. doi: 10.1016/j.nut.2020.110863. Epub 2020 May 17. Nutrition. 2020. PMID: 32593948
-
Probiotic administration reduces mortality and improves intestinal epithelial homeostasis in experimental sepsis.Anesthesiology. 2013 Jul;119(1):166-77. doi: 10.1097/ALN.0b013e318291c2fc. Anesthesiology. 2013. PMID: 23571641 Free PMC article.
-
Lactobacillus rhamnosus GG and Bifidobacterium longum attenuate lung injury and inflammatory response in experimental sepsis.PLoS One. 2014 May 15;9(5):e97861. doi: 10.1371/journal.pone.0097861. eCollection 2014. PLoS One. 2014. PMID: 24830455 Free PMC article.
-
Lactobacillus rhamnosus GG Ameliorates Liver Injury and Hypoxic Hepatitis in Rat Model of CLP-Induced Sepsis.Dig Dis Sci. 2019 Oct;64(10):2867-2877. doi: 10.1007/s10620-019-05628-0. Epub 2019 Apr 30. Dig Dis Sci. 2019. PMID: 31049763
Cited by
-
Opioids and Sepsis: Elucidating the Role of the Microbiome and microRNA-146.Int J Mol Sci. 2022 Jan 20;23(3):1097. doi: 10.3390/ijms23031097. Int J Mol Sci. 2022. PMID: 35163021 Free PMC article. Review.
-
Probiotics in the Intensive Care Unit.Antibiotics (Basel). 2022 Feb 8;11(2):217. doi: 10.3390/antibiotics11020217. Antibiotics (Basel). 2022. PMID: 35203819 Free PMC article. Review.
-
Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates microbiota dysbiosis in an experimental model of sepsis.Int J Mol Med. 2019 Mar;43(3):1139-1148. doi: 10.3892/ijmm.2019.4050. Epub 2019 Jan 7. Int J Mol Med. 2019. PMID: 30628657 Free PMC article.
-
Therapeutic Potential of the Gut Microbiota in the Management of Sepsis.Crit Care. 2020 Mar 24;24(1):105. doi: 10.1186/s13054-020-2780-3. Crit Care. 2020. PMID: 32204720 Free PMC article. Review.
-
The Neutrophil: Constant Defender and First Responder.Front Immunol. 2020 Sep 24;11:571085. doi: 10.3389/fimmu.2020.571085. eCollection 2020. Front Immunol. 2020. PMID: 33072112 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous